1 (877) 284-6600
Local (816) 221-6600

Dangerous Pharmaceuticals

FDA Approves Boxed Warning on Xeljanz (Tofacitinib)

Xeljanz FDA Warning

The US Food and Drug Administration approved new warnings about an increased risk of blood clots and of death with the 10 mg twice daily dose of tofacitinib (Xeljanz, Xeljanz XR), which is used in patients with ulcerative colitis.

This new warning, issued July 26, 2019, comes just a few months after the first warning issued February 25, 2019.

Read More


Blood Pressure Medication Recall Expanded

Blood Pressure Med Recall

Torrent Pharmaceuticals is recalling an additional 36 lots of Losartan potassium tablets and 68 lots Losartan potassium/hydrochlorothiazide tablets. This is the fourth expansion of the original recall posted in December 2018 of blood pressure medications manufactured by the company.

Read More


Xarelto Lawsuits: $775 Million Settlement Reached

Xarelto lawsuits

Bayer and Johnson & Johnson, the companies who make and sell the blood thinner Xarelto, have reached a settlement in 25,000 lawsuits. While the companies have not admitted liability, they have agreed to pay a $775 million dollar settlement.

Read More


What is Happening with Abilify Lawsuits?

Abilify - compulsive urge disorder

If you take the drug Abilify or know someone who does, here is a brief summary of what has been happening with the litigation.

Read More


Black Box Warning for Diabetes Medicine Invokana

Invokana pills

In May 2017, the FDA issued a safety warning indicating that Invokana, used to treat diabetes, could increase the risk of leg and foot amputations. This means that the drug now carries a boxed warning about the amputation risks. This is the strongest label warning that the FDA can require.

Read More


Lawsuit Update: Proton Pump Inhibitor Heartburn Meds, Kidney Damage

Kidney Disease and PPIs

A growing number of Proton Pump Inhibitor (PPI) lawsuits have been filed against the manufacturers of PPI medications. Plaintiffs allege that as a result of taking a PPI for gastric acid-related conditions, they have been diagnosed with kidney injuries including Acute Interstitial Nephritis (AIN), chronic kidney disease and renal failure.

Read More


Xarelto Lawsuit Update: First Bellwether Trial to Begin in April

Xarelto Lawsuit Update

Originally scheduled to start in February, the first Bellwether trial for the blood thinner, Xarelto, will now begin on April 24, 2017 in the Eastern District of Louisiana.

Read More


Abilify Lawsuits Centralized in MDL

Bottle of Abilify

The U.S. Judicial Panel on Multidistrict Litigation (JPML) has decided to consolidate all pending Abilify cases against Bristol-Myers Squibb and Otsuka Pharmaceuticals. This decision will centralize all cases filed in the federal court system before one judge, the Honorable M. Casey Rodgers in the U.S. District Court for the Northern District of Florida.

Read More


Does Abilify Affect Your Impulse Control?

Abilify gambling addiction

Is it true that Abilify, one of the top-selling prescription drugs in the United States, may lead to impulse-control disorders? According to the U.S. Food & Drug Administration a link does exist.

On May 3, 2016, the FDA issued a warning that the drug Abilify has been linked to side effects such as pathological gambling, binge eating and hyper-sexuality.

Read More


Nexium, Prilosec & Prevacid May Cause Severe Kidney Problems



One of the kidney problems caused by Proton Pump Inhibitors like Nexium, Prilosec, and Prevacid may be Acute Interstitial Nephritis. Acute Interstitial Nephritis (AIN) is characterized by inflammatory cells infiltrating the interstitium of the kidney and may lead to acute kidney failure. Delays in diagnosis and persistent use of the drug causing AIN (such as Nexium, Prilosec, or Prevacid), can cause Chronic Kidney Failure.

Read More